Post-approval studies (Phase 4)Looking for participantsNCT06031233
What this trial is testing
Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie
Who this might be right for
OncologyInfusion Reaction
Isala 776
Showing 4 of 0 results